dysmorphic features. The baby had a palpable right upper quadrant (RUQ) mass that measured approximately 4-5 cm. An abdominal sonogram was performed on the first day of life (Figure 1 ). On the second day of life, the patient was taken to the operating room where a RUQ cystogram was performed under laparoscopic control ( Figure 2 ). The bilirubin was only mildly elevated at 1.6 mg% (normal 0.3-1.1 mg%). 
Denouement and discussion
The initial abdominal sonogram demonstrated a large RUQ cyst in the porta hepatis. The main intrahepatic biliary ducts were dilated. A gallbladder was identified. The mass displaced the hepatic artery anteriorly. Echogenic debris was present in the dependent portion of the cyst. Given this appearance, a choledochal cyst was considered most likely. The infant was taken to the operating room where the cystogram demonstrated a choledochal cyst without biliary atresia (BA) as contrast flowed freely antegrade into the duodenum and retrograde into the slightly dilated intrahepatic biliary tree. Choledochal cysts were reportedly described first by Abraham Vater in 1723. 1 Choledochal cysts are cystic dilatations of the extrahepatic and intrahepatic biliary tree or both. They are approximately three times more common in women than in men. Although the etiology is not known, it has been shown that in at least 94% of choledochal cysts there are anomalous insertions of the common bile duct into the pancreatic duct. 2 It is believed that this allows reflux of pancreatic enzymes into the biliary tree leading to ductal dilatation and scarring. Among the various classification schemes, that of Todani is widely used. The cystic dilatation in this patient is that of Todani type I. This comprises 80-90% of all choledochal cysts. 1 Todani type II are diverticular dilatations of the common bile duct. Todani type III is a choledocele, a malformation of the ampulla of Vater that does not have a high insertion of the pancreatic duct and common bile duct. Type IV is a choledochal cyst associated with other intrahepatic and extrahepatic cysts or Caroli's disease. Type V is intrahepatic cystic biliary dilatation or Caroli's disease.
Type I choledochal cysts are associated with a significant risk of development of biliary adenocarcinomas. 3 The frequency of these malignancies increases with age, but has been reported in patients as young as 12 years old. 4 The lifetime risk of malignancy is 25-40%. Because of this risk of malignancy, the definitive surgical treatment should be resection of the entire choledochal cyst and as much of the biliary system as possible. 3 Although 86% of cases present before 16 years of age, neonatal presentation is uncommon. 5 The most common presentation of these lesions is jaundice, pain and a RUQ mass. 5 The primary differential consideration is BA with a cyst (Japanese type I cyst). [6] [7] [8] This is a critical differential because of the different surgical implications. Patients with BA type I cyst have a very high incidence of hepatic fibrosis. In addition to absence of demonstrable bile flow into the duodenum at cholangiography in patients with BA type I cyst, liver biopsy can also be helpful, because in typical choledochal cysts there are normal interlobar bile ducts. However, in BA type I cyst there are no interlobar bile ducts and bile ductular proliferation. 7 Neonatal biliary choledochal cysts even without atresia (those discovered in patients younger than 4 months) have been reported to develop hepatic fibrosis, making early surgical intervention warranted to prevent progression. 6 Figure 2 Intraoperative cystography. Contrast injected into the porta hepatis cyst flows into the slightly dilated intrahepatic biliary tree and into the duodenum and jejunum (black arrow).
